In conclusion, autophagy is closely related to NAFLD, so we expect mTOR to be a target for autophagy intervention, and further research will hopefully provide important clues for the prevention and treatment of liver diseases (Figure 3). Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.